Skip to main content

Chinese firm's COVID-19 drug claims draw skepticism

The Hong Kong-listed company's stock price has nearly quadrupled since March 1 as some analysts wrote about the big sales potential for a COVID-19 ...

Comments

Popular posts from this blog